AKBA logo

Akebia Therapeutics, Inc. (AKBA) Total expenses

Annual total expenses:

$229.59M-$16.96M(-6.88%)
December 31, 2024

Summary

  • As of today (September 15, 2025), AKBA annual total expenses is $229.59 million, with the most recent change of -$16.96 million (-6.88%) on December 31, 2024.
  • During the last 3 years, AKBA annual total expenses has fallen by -$264.08 million (-53.49%).
  • AKBA annual total expenses is now -66.18% below its all-time high of $678.76 million, reached on December 31, 2020.

Performance

AKBA Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

Quarterly total expenses:

$62.23M+$11.00M(+21.48%)
June 1, 2025

Summary

  • As of today (September 15, 2025), AKBA quarterly total expenses is $62.23 million, with the most recent change of +$11.00 million (+21.48%) on June 1, 2025.
  • Over the past year, AKBA quarterly total expenses has increased by +$9.99 million (+19.14%).
  • AKBA quarterly total expenses is now -76.60% below its all-time high of $265.89 million, reached on June 30, 2020.

Performance

AKBA Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

AKBA Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.9%+19.1%
3 y3 years-53.5%-35.8%
5 y5 years-62.6%-76.6%

AKBA Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-53.5%at low-39.5%+23.0%
5 y5-year-66.2%at low-76.6%+23.0%
alltimeall time-66.2%+2701.2%-76.6%+9921.7%

AKBA Total expenses History

DateAnnualQuarterly
Jun 2025
-
$62.23M(+21.5%)
Mar 2025
-
$51.22M(-26.1%)
Dec 2024
$229.59M(-6.9%)
$69.30M(+20.6%)
Sep 2024
-
$57.47M(+10.0%)
Jun 2024
-
$52.23M(+3.2%)
Mar 2024
-
$50.59M(-9.0%)
Dec 2023
$246.55M(-36.2%)
$55.58M(-1.7%)
Sep 2023
-
$56.53M(-16.3%)
Jun 2023
-
$67.55M(+1.0%)
Mar 2023
-
$66.88M(+4.0%)
Dec 2022
$386.71M(-21.7%)
$64.28M(-37.5%)
Sep 2022
-
$102.81M(+6.1%)
Jun 2022
-
$96.92M(-21.9%)
Mar 2022
-
$124.12M(-2.7%)
Dec 2021
$493.67M(-27.3%)
$127.54M(+17.8%)
Sep 2021
-
$108.30M(-20.3%)
Jun 2021
-
$135.95M(+11.5%)
Mar 2021
-
$121.88M(-15.2%)
Dec 2020
$678.76M(+10.4%)
$143.70M(+19.8%)
Sep 2020
-
$119.95M(-54.9%)
Jun 2020
-
$265.89M(+78.2%)
Mar 2020
-
$149.22M(-9.0%)
Dec 2019
$614.66M(+75.0%)
$164.04M(+11.9%)
Sep 2019
-
$146.56M(-7.8%)
Jun 2019
-
$158.97M(+9.6%)
Mar 2019
-
$145.09M(+21.0%)
DateAnnualQuarterly
Dec 2018
$351.33M(+37.8%)
$119.90M(+51.4%)
Sep 2018
-
$79.22M(-4.4%)
Jun 2018
-
$82.86M(+19.5%)
Mar 2018
-
$69.35M(-7.6%)
Dec 2017
$254.90M(+85.7%)
$75.04M(+16.5%)
Sep 2017
-
$64.42M(+28.7%)
Jun 2017
-
$50.04M(-23.5%)
Mar 2017
-
$65.41M(+66.0%)
Dec 2016
$137.28M(+126.1%)
$39.40M(+8.5%)
Sep 2016
-
$36.31M(+1.5%)
Jun 2016
-
$35.78M(+38.7%)
Mar 2016
-
$25.80M(+29.9%)
Dec 2015
$60.72M(+63.9%)
$19.86M(+2.0%)
Sep 2015
-
$19.48M(+82.2%)
Jun 2015
-
$10.69M(-0.1%)
Mar 2015
-
$10.70M(+3.1%)
Dec 2014
$37.03M(+181.3%)
$10.37M(+10.9%)
Sep 2014
-
$9.35M(+22.7%)
Jun 2014
-
$7.62M(-92.1%)
Mar 2014
-
$96.60M(+976.6%)
Dec 2013
$13.17M(+60.7%)
$8.97M(+138.1%)
Sep 2013
-
$3.77M(+33.1%)
Jun 2013
-
$2.83M(+355.9%)
Mar 2013
-
$620.90K(-80.9%)
Dec 2012
$8.20M(-55.1%)
-
Dec 2012
-
$3.26M
Dec 2011
$18.27M
-

FAQ

  • What is Akebia Therapeutics, Inc. annual total expenses?
  • What is the all time high annual total expenses for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. annual total expenses year-on-year change?
  • What is Akebia Therapeutics, Inc. quarterly total expenses?
  • What is the all time high quarterly total expenses for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. quarterly total expenses year-on-year change?

What is Akebia Therapeutics, Inc. annual total expenses?

The current annual total expenses of AKBA is $229.59M

What is the all time high annual total expenses for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high annual total expenses is $678.76M

What is Akebia Therapeutics, Inc. annual total expenses year-on-year change?

Over the past year, AKBA annual total expenses has changed by -$16.96M (-6.88%)

What is Akebia Therapeutics, Inc. quarterly total expenses?

The current quarterly total expenses of AKBA is $62.23M

What is the all time high quarterly total expenses for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high quarterly total expenses is $265.89M

What is Akebia Therapeutics, Inc. quarterly total expenses year-on-year change?

Over the past year, AKBA quarterly total expenses has changed by +$9.99M (+19.14%)
On this page